Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice.
about
Baclofen administration alters fear extinction and GABAergic protein levels.Deficits in emotional learning and memory in an animal model of schizophreniaGenetic background differences and nonassociative effects in mouse trace fear conditioningGalanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze.Contextual and cued fear conditioning test using a video analyzing system in mice.Galanin inhibition of voltage-dependent Ca(2+) influx in rat cultured myenteric neurons is mediated by galanin receptor 1.Mouse behavioral assays relevant to the symptoms of autism.Durable fear memories require PSD-95.Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative DiseasesGalanin and cognition.Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease.Impairment of memory consolidation by galanin correlates with in vivo inhibition of both LTP and CREB phosphorylation.Galanin receptors as a potential target for neurological disease.Prefrontal cognitive deficits in mice with altered cerebral cortical GABAergic interneurons.An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze.Expression and plasticity of galanin systems in cortical neurons, oligodendrocyte progenitors and proliferative zones in normal brain and after spreading depression.Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor.Administration of donepezil does not rescue galanin-induced spatial learning deficits.
P2860
Q30448773-DE69297E-E892-4FCF-B225-C91D5AAAEA22Q30452228-80DBC667-5691-472E-AEB9-C28DD498515DQ30493601-A87E23D5-A2A9-4715-968D-322953833EC1Q30499206-7B8CA26E-B284-4CC5-AE5B-9BFCAEB238A8Q34004984-DB1D5836-7285-4F90-A456-E347675D07F6Q34111561-680768EA-2F75-4518-A442-B483CB551986Q34699041-774407F0-4410-40B0-AD59-AD015337A924Q35748848-48B09DF4-A147-461B-AC72-F7F4D5F1A881Q35768362-FA5464AA-B222-4F43-8956-831BAE1227FAQ36089985-3EDFCD71-0ABF-48B4-94B3-68FB8EF5E205Q37171921-3B280209-C0CD-4534-A959-A060F3CB2B71Q37436783-3066D503-0D5E-426A-967C-A54ADFF057D1Q38556483-014CCEEB-76CB-4479-BD19-27FFA402DB4BQ41845548-5D000CB5-96BB-4A88-BAD1-3BF7B46D61CEQ42710424-5601B73C-812D-451C-A8A5-008611395687Q44407084-72B80246-1AA3-4AFC-A292-A0D35696FB5BQ47604212-D3BADDBE-20B4-468D-AB33-B4C16DA771D9Q47965028-8EEBE066-ED87-4587-9C2C-C9487D2049C2Q50790052-408AE28C-6B6F-4D8B-BE85-746D0601FDFE
P2860
Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Deficits in trace cued fear co ...... verexpressing transgenic mice.
@ast
Deficits in trace cued fear co ...... verexpressing transgenic mice.
@en
type
label
Deficits in trace cued fear co ...... verexpressing transgenic mice.
@ast
Deficits in trace cued fear co ...... verexpressing transgenic mice.
@en
prefLabel
Deficits in trace cued fear co ...... verexpressing transgenic mice.
@ast
Deficits in trace cued fear co ...... verexpressing transgenic mice.
@en
P2093
P2860
P356
P1433
P1476
Deficits in trace cued fear co ...... verexpressing transgenic mice.
@en
P2093
Andrew Holmes
Ashley P Harris
Craige C Wrenn
Grzegorz Starosta
Jacqueline N Crawley
Jefferson W Kinney
Katharine C Long
Rebecca J Yang
P2860
P304
P356
10.1101/M.49502
P577
2002-07-01T00:00:00Z